NXGL

Nexgel Inc

Add to Watchlist

Advanced Chart

2.300

-0.05(-2.128%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

2.410

Open

2.4019

VWAP

2.36

Vol

47.62K

Mkt Cap

18.56M

Low

2.250

Amount

112.17K

EV/EBITDA(TTM)

Total Shares

6.23M

19.59M

EV/OCF(TTM)

P/S(TTM)

1.51

NexGel, Inc. is a provider of healthcare, beauty, and over-the-counter products, including ultra-gentle, high-water-content hydrogels. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. The Company operates through two segments: NexGel and CGN. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CGN segment comprises CG Converting and Packaging, LLC (CGN), a joint venture with C.G. Laboratories Inc. (CG Labs) used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Silly George.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

3.63M

+19.47%

3.16M

+7.62%

3.08M

+113.89%

Estimates Revision

The market is revising Downward the revenue expectations for NEXGEL, Inc. (NXGL) for FY2025, with the revenue forecasts being adjusted by -3.77% over the past three months. During the same period, the stock price has changed by 1.32%.

Revenue Estimates for FY2025

Revise Downward

-3.77%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Up

+1.32%

In Past 3 Month

2 Analyst Rating

Wall Street analysts forecast NXGL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NXGL is 4.25 USD with a low forecast of 2.50 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

1 Hold

0 Sell

Moderate Buy

Current: 2.300

Low

2.50

Averages

4.25

High

6.00

Current: 2.300

Low

2.50

Averages

4.25

High

6.00

The End

No Data

Valuation Metrics

The current forward P/E ratio for Nexgel Inc (NXGL.O) is -39.17, compared to its 5-year average forward P/E of -15.00. For a more detailed relative valuation and DCF analysis to assess Nexgel Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-15.00

Current PE

-39.17

Overvalued PE

6.30

Undervalued PE

-36.30

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

1.45

Current EV/EBITDA

33.14

Overvalued EV/EBITDA

8.36

Undervalued EV/EBITDA

-5.47

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

2.56

Current PS

1.22

Overvalued PS

3.93

Undervalued PS

1.18